已发表论文

电针治疗卵巢储备功能减退:一项随机、安慰剂对照试验方案

 

Authors Tang H, Wang JX, Zheng SZ, Jia YF, Yu X, Zhao NN, Yang YH, Lin LP , Li SY, Zhao H

Received 21 March 2025

Accepted for publication 18 July 2025

Published 30 July 2025 Volume 2025:18 Pages 4341—4352

DOI https://doi.org/10.2147/JMDH.S529775

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Krzysztof Laudanski

Han Tang,1,2 Jia-Xuan Wang,1 Shi-Zhong Zheng,1 Yan-Fei Jia,1 Xin Yu,1 Na-Na Zhao,1 Yun-Hong Yang,1,2 Lv-Ping Lin,1,2 Si-Yuan Li,2 Hong Zhao1,2 

1Department of Acupuncture, Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine, Shenzhen, Guangdong, People’s Republic of China; 2Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China

Correspondence: Hong Zhao, Email hongzhao2005@aliyun.com

Introduction: Diminished ovarian reserve (DOR) is characterized by a reduced response to ovarian stimulation and a decline in fertility potential among women of reproductive age. Although previous research has suggested potential benefits of acupuncture for DOR, the evidence remains inconclusive. This study evaluates the effectiveness of electro-acupuncture in patients with DOR by examining changes in ovarian reserve indicators and reproductive outcomes. The study aims to determine whether electro-acupuncture significantly improves ovarian reserve markers and reproductive outcomes in women with DOR, thereby informing clinical decision-making.
Methods and Analysis: A randomized, subject- and assessor-blinded, placebo-controlled trial will be conducted in two hospitals in Shenzhen, China. A total of 112 participants (20– 48 yr) will be allocated to either the electro-acupuncture (EA) group or the sham electro-acupuncture (SA) group in a 1:1 ratio. Each participant will receive 3 treatment sessions per week over a continuous period of 12 weeks. The primary outcome is the change in antral follicle count, with an anticipated mean increase of approximately 2.2 follicles based on previous meta-analytic findings. Secondary outcomes will include changes in serum basal hormone levels, serum anti-Müllerian hormone levels, and self-rating anxiety, depression, and Kupperman Index scores compared to baseline. Subgroup analyses will explore variations in pregnancy outcomes (eg, clinical pregnancy rate, live birth rate), age groups (≤ 32, 32– 40, ≥ 40 years), and ovulation induction outcomes (eg, number of oocytes retrieved, MII oocyte rate). Adverse events will be recorded following each session of treatment, and a blinded evaluation is conducted upon the completion of the treatment. Study results will be primarily analyzed using the full analysis set, supplemented by the per-protocol set.
Ethics and Dissemination: This protocol have been approved by the Ethics Committee of Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine (No.2023-LHQZYYYXLL-KY-147) and Luohu People’s Hospital (No.2024-LHQRMYY-KYLL-009). The results will be disseminated to participants, the public, and other relevant groups through open-access journals and conferences.
Trial Registration Number: ISRCTN:69623204. Registered on 10 January 2024.

Keywords: acupuncture, diminished ovarian reserve, study protocol, randomized controlled trial